ISRG
Intuitive Surgical, Inc.
Healthcare · Medical Instruments & Supplies · United States · Stock
Score Breakdown
Scored for Aggressive Growth profile
Sub-scores are 0–20 each; Model Score is weighted by your selected investment goal. How it works →
Why Ranked Here
- The profitability sub-score of 20.0 and growth sub-score of 15.0 provide a strong combined foundation, anchoring the composite at 56.2 by reflecting genuine operating quality visible in the FY 2025 10-K filing.
- The momentum sub-score of 17.0 adds further support by indicating that quarterly revenue and earnings trends within the fiscal year were broadly positive, contributing meaningfully to the overall composite.
- Despite strong operating metrics, the dividend sub-score of 0.0 and theme sub-score of 0.0 each contribute nothing to the composite, and combined with a weak financial health sub-score of 8.0, these gaps structurally cap the total score at the mid-range level.
Why Not Higher
- The dividend sub-score of 0.0 and theme sub-score of 0.0 together remove up to 40 potential points from the scoring framework, and since Intuitive Surgical does not pay dividends and did not qualify for macro theme exposure under the current model, these categories provide no upward contribution to the composite.
- The financial health sub-score of 8.0 out of 20 drags significantly on the composite, indicating that despite excellent profitability, the company's leverage or balance sheet characteristics as reported in the 10-K are not at a level the model rewards highly.
Data Confidence
6 / 10
Medium — some data gaps
Research Summary
AI-generated analysis reflects data and conditions as of the report date shown above. Verify any specific figures through primary sources before acting on this analysis.
Intuitive Surgical, Inc. is the dominant developer and manufacturer of robotic-assisted surgical systems, most notably its da Vinci surgical platform, which is used in minimally invasive procedures across urology, gynecology, general surgery, and thoracic applications. The company operates a razor-and-blade business model: it places high-cost robotic systems in hospitals and generates recurring revenue through instruments, accessories, and service contracts tied to each installed system. From the FY 2025 10-K filing, ISRG earned a composite model score of 56.2/100, reflecting genuinely strong profitability and growth sub-scores (20.0 and 15.0 respectively) that confirm healthy net and operating margins alongside meaningful year-over-year revenue and earnings expansion. However, the financial health sub-score of 8.0 signals concern around leverage or balance sheet structure relative to peers, and the momentum sub-score of 17.0 — while solid — did not reach the highest tier, suggesting quarterly improvement in revenues and margins has been positive but not uniformly accelerating. The dividend sub-score of 0.0 confirms the company does not distribute dividends, and the theme sub-score of 0.0 indicates the filing-based macro theme mapping did not capture qualifying thematic exposures under the current scoring model. The key research tradeoff is between a genuinely high-quality, profitable, and growing business and a model profile that is incomplete due to missing metrics and zero scores in two categories, pulling the composite figure below what the core operating results might otherwise suggest.
Plain English
Intuitive Surgical makes the da Vinci robotic surgery system used in hospitals around the world, and it makes money both from selling the robots and from the supplies and maintenance contracts that come with them. A model score of 56.2 out of 100 means the research model sees real strengths — particularly in profitability and revenue growth — but also some concerns, especially around the balance sheet and areas where data was unavailable. The Medium risk rating reflects that this is a well-established company in a specialized industry, but one where the full scoring picture has gaps that make a confident high score difficult to assign. Researchers treating this as an aggressive growth candidate should examine the financial health details and watch for future filings that might fill in missing data points.
Bull Case vs. Bear Case
Bull Case
- The profitability sub-score of 20.0 out of 20 is the maximum possible, indicating that net margins, operating margins, and return on assets derived from the FY 2025 10-K filing are among the strongest observable in the scoring model.
- The growth sub-score of 15.0 out of 20 reflects meaningful year-over-year revenue, net income, and EPS expansion as reported in the annual filing, consistent with ISRG's recurring instrument and service revenue streams scaling alongside its growing installed base of da Vinci systems.
- The momentum sub-score of 17.0 out of 20 indicates that quarterly sequential improvement in revenues, earnings, and margins was strong across the fiscal year, suggesting the company's operational trajectory heading into future periods is constructive based on filing data.
Bear Case
- The financial health sub-score of 8.0 out of 20 is notably weak relative to the company's strong profitability scores, pointing to leverage, interest coverage, or balance sheet composition concerns visible in the 10-K that offset the otherwise high-quality earnings profile.
- With only 6 out of 10 core metrics successfully mapped from the SEC EDGAR filing, the model is operating with an incomplete data picture, and the missing metrics introduce uncertainty that prevents a higher-confidence composite score.
- The confidence rating of 6.0 out of 10 reflects the incomplete metric mapping, meaning the 56.2 composite score carries more model uncertainty than scores derived from fuller data sets, which is a meaningful caution for researchers relying on this output for comparative analysis.
What Could Change the Picture
Bullish Triggers
- A future filing that demonstrates material improvement in balance sheet leverage ratios or interest coverage — driving the financial health sub-score meaningfully above its current 8.0 level — would strengthen the overall research case and increase composite score confidence.
- Successful mapping of the remaining 4 out of 10 core metrics in a subsequent filing period, particularly if those metrics reflect strong operating or cash flow characteristics, would raise model confidence above 6.0 and could meaningfully lift the composite score.
Bearish Triggers
- A deceleration in quarterly revenue or earnings improvement visible in the next annual filing — reducing the momentum sub-score from its current 17.0 — would signal that the operational trajectory supporting the current research view is weakening.
- Any deterioration in net or operating margins in a future 10-K filing that causes the profitability sub-score to fall from its maximum 20.0 would fundamentally change the research profile, as profitability is the single largest contributor to the current composite score.
Red Flags
- The financial health sub-score of 8.0 out of 20 is a material underperformance relative to other sub-scores and suggests that leverage ratios, interest coverage, or balance sheet structure visible in the FY 2025 10-K warrant specific scrutiny before drawing conclusions about financial resilience.
- Four out of ten core metrics were not successfully mapped from the filing, raising the possibility that structural or reporting characteristics of Intuitive Surgical's 10-K limited the model's ability to fully assess the company's financial position.
Risk Profile
Medium RiskThe Medium risk rating reflects that Intuitive Surgical operates in a specialized, capital-intensive medical technology segment with regulatory dependencies and a concentrated product platform, but also benefits from an entrenched installed base and recurring revenue streams that moderate downside volatility relative to early-stage or speculative healthcare names. The incomplete metric mapping (6 of 10) introduces additional model-level uncertainty that contributes to the Medium designation even though core profitability signals are strong.
Key Catalysts to Watch
The primary variables to monitor in future SEC filings are the trajectory of installed base growth and the associated instrument and service revenue per system, which directly drive the recurring revenue model that underpins ISRG's profitability scores. Researchers should also watch for changes in balance sheet structure or leverage disclosures in subsequent 10-K filings that could either validate or reverse the current financial health sub-score concern.
This report is for educational and research purposes only. It does not constitute financial, investment, legal, or tax advice — always conduct your own due diligence before making investment decisions.